APA (7th ed.) Citation

Dimitris K. Karathanasis, Anna Rapti, Adrianos Nezos, Charalampos Skarlis, Constantinos Kilidireas, Clio P. Mavragani, . . . Maria Eleftheria Evangelopoulos. (2022). Differentiating central nervous system demyelinating disorders: The role of clinical, laboratory, imaging characteristics and peripheral blood type I interferon activity. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Dimitris K. Karathanasis, Anna Rapti, Adrianos Nezos, Charalampos Skarlis, Constantinos Kilidireas, Clio P. Mavragani, Clio P. Mavragani, Clio P. Mavragani, and Maria Eleftheria Evangelopoulos. Differentiating Central Nervous System Demyelinating Disorders: The Role of Clinical, Laboratory, Imaging Characteristics and Peripheral Blood Type I Interferon Activity. Frontiers Media S.A., 2022.

MLA (9th ed.) Citation

Dimitris K. Karathanasis, et al. Differentiating Central Nervous System Demyelinating Disorders: The Role of Clinical, Laboratory, Imaging Characteristics and Peripheral Blood Type I Interferon Activity. Frontiers Media S.A., 2022.